Novavax, Inc. (NASDAQ:NVAX)
$2.31
0.01 (+0.43%)
| CAPS Rating |
|
|---|---|
| Open | $2.32 |
| Previous Close | $2.31 |
| Daily Range | $2.30 - $2.34 |
| 52-Week Range | $0.52 - $7.79 |
| Market Cap | $215.96M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 554,127 |
| Average Daily Volume | 0 |
NVAX
VS S&P 500 (SPY)
NVAX News and Commentary
- This Just In: Upgrades and Downgrades – The Motley Fool
- Cash In on an Unstable Dollar With This Stock – The Motley Fool
- A Big Upgrade for Cepheid – The Motley Fool
- Swine Flu Just Isn't Bringing Home the Bacon – The Motley Fool
- This Just In: Upgrades and Downgrades – The Motley Fool
- UPDATE 1-Novavax says H1N1 flu vaccine shows positive results – Reuters
- The One Stock You Must Buy – The Motley Fool
- Novavax begins H1N1 flu vaccine study in Mexico, shares rise – Reuters
- 5 Stocks Bucking the Downtrend – The Motley Fool
How do you think NVAX will perform vs the S&P 500?
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
Powered by: CAPSAll Members
200
Outperform
95
Underperform
All-Star Members
69
Outperform
52
Underperform
Wall Street
4
Outperform
1
Underperform
RSS Headlines
Fool UK
